Intract’s founder and CSO awarded £10 million EPSRC grant in collaboration with Cambridge, Imperial, Birmingham and Glasgow Universities
October 17, 2018 | Featured
Intract’s Phloral® technology rated among top emerging drug delivery technologies
October 01, 2018 | Conferences
Intract will be attending BioJapan 2018
September 27, 2018 | News
An Interview with Intract's CEO: How Intract Is Helping Shape Microbiome-Based Therapies
September 27, 2017 | Phloral
FIN-403 a Phloral® coated microbial therapeutic shows promising clinical results
